The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Oncogene addiction: setting the stage for molecularly targeted cancer therapy
Open accessAbstract
In pugilistic parlance, the one-two punch is a devastating combination of blows, with the first punch setting the stage and the second delivering the knock-out. This analogy can be extended to molecularly targeted cancer therapies, with oncogene addiction serving to set the stage for tumor cell killing by a targeted therapeutic agent. While in vitro and in vivo examples abound documenting the existence of this phenomenon, the mechanistic underpinnings that govern oncogene addiction are just beginning to emerge. Our current inability to fully exploit this weakness of cancer cells stems from an incomplete understanding of oncogene addiction, which nonetheless represents one of the rare chinks in the formidable armor of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–219 of 219
v-Src Generates a p53-Independent Apoptotic Signal
Webb, B. L., Jimenez, E., & Martin, G. S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9271-9280.2000 · Cited by 53
Alterations of the Tumor Suppressor Gene ARLTS1 in Ovarian Cancer
Petrocca, F., Iliopoulos, D., Qin, H. R., Nicoloso, M. S., Yendamuri, S., Wojcik, S. E., Shimizu, M., Leva, G. D., Vecchione, A. M., Trapasso, F., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2289 · Cited by 52
Sarti, M., Sevignani, C., Calin, G. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.806.11.2 · Cited by 49
Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy
Stabile, L. P., Lyker, J. S., Huang, L., & Siegfried, J. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302169 · Cited by 47
Using cancer genetics to guide the selection of anticancer drug targets
Reddy, A., & Kaelin, W. G. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00178-9 · Cited by 46
Vater, C. A., Bartle, L. M., Dionne, C. A., Littlewood, T. D., & Goldmacher, V. S. (1996) · PubMed · Cited by 42
Yoshimoto, A., Inuzuka, K., Kita, T., Kawashima, A., & Kasahara, K. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31803b8acb · Cited by 31
Ohnishi, Y., Nakamura, H., Yoshimura, M., et al. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.187 · Cited by 31
Consequences of Nonadaptive Alterations in Cancer
Kamb, A. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-11-0732 · Cited by 31
Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line
Tokunaga, T., Tsuchida, T., Kijima, H., Okamoto, K., Oshika, Y., Sawa, N., Ohnishi, Y., Yamazaki, H., Miura, S., Ueyama, Y., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1363 · Cited by 30
Preston, G. A., Srinivasan, D., & Barrett, J. C. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400637 · Cited by 26
Adachi, J.-I., Ookawa, K., Shiseki, M., Okazaki, T., Tsuchida, S., Morishita, K., & Yokota, J. (1996) · PubMed · Cited by 25
Qanungo, S., Haldar, S., & Basu, A. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80030-1 · Cited by 24
Correlation of genetic instability and apoptosis in the presence of oncogenic Ki-Ras
Chen, C., Liou, J. S., Forman, L. W., & Faller, D. V. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400448 · Cited by 19
Ad-IRF-1 Induces Apoptosis in Esophageal Adenocarcinoma
Watson, G. A., de Oliveira, P. E. Q., Stang, M. T., Armstrong, M. J., Gooding, W. E., Kuan, S., Yim, J. H., & Hughes, S. J. (2006) · Neoplasia · doi:10.1593/neo.05559 · Cited by 16
Pichiorri, F., Trapasso, F., Palumbo, T., Aqeilan, R. I., Drusco, A., Blaser, B. W., Iliopoulos, D., Caligiuri, M. A., Huebner, K., & Croce, C. M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2581 · Cited by 16
Liu, Y., Hong, Y., Androphy, E. J., & Chen, J. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000640200 · Cited by 13
Janus faces of ras: anti or pro-apoptotic?
Arber, N. (1999) · APOPTOSIS · doi:10.1023/a:1009651406017 · Cited by 12
v-Jun sensitizes cells to apoptosis by a mechanism involving mitochondrial cytochrome C release
MacLaren, A., Clark, W. A., & Gillespie, D. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203954 · Cited by 7
Cited by
Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
Hepatocellular carcinoma: clinical frontiers and perspectives
Bruix, J., Gores, G. J., & Mazzaferro, V. (2014) · Gut · doi:10.1136/gutjnl-2013-306627 · Cited by 1,364
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Wilson, T. R., Fridlyand, J., Yan, Y., Penuel, E., Burton, L., Chan, E., Peng, J., Lin, E., Wang, Y., Sosman, J., et al. (2012) · Nature · doi:10.1038/nature11249 · Cited by 1,134
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
Wagle, N., Emery, C., Berger, M. F., Davis, M. J., Sawyer, A., Pochanard, P., Kehoe, S. M., Johannessen, C. M., MacConaill, L. E., Hahn, W. C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.2312 · Cited by 1,005
OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
Medina, P. P., Nolde, M., & Slack, F. J. (2010) · Nature · doi:10.1038/nature09284 · Cited by 971
Metadata
- Authors
- Sharma, S. V., & Settleman, J.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2007-12-13
- Volume
- 21
- Issue
- 24
- Pages
- 3214-3231
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2123326378
- Cited by
- 441
- References
- 219
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.